Next Article in Journal
TOE1/TOE2 Interacting with GIS to Control Trichome Development in Arabidopsis
Next Article in Special Issue
Biophysics in Membrane of Cells
Previous Article in Journal
In Situ Raman Analysis of Biofilm Exopolysaccharides Formed in Streptococcus mutans and Streptococcus sanguinis Commensal Cultures
Previous Article in Special Issue
Lipids in Mitochondrial Macroautophagy: Phase Behavior of Bilayers Containing Cardiolipin and Ceramide
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dimethylglycine Can Enhance the Cryopreservation of Red Blood Cells by Reducing Ice Formation and Oxidative Damage

1
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China
2
School of Materials Science and Engineering, Central South University, Changsha 410013, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2023, 24(7), 6696; https://doi.org/10.3390/ijms24076696
Submission received: 10 February 2023 / Revised: 15 March 2023 / Accepted: 31 March 2023 / Published: 3 April 2023
(This article belongs to the Special Issue Biophysics in Membrane of Cells)

Abstract

:
The cryopreservation of red blood cells (RBCs) holds great potential for ensuring timely blood transfusions and maintaining an adequate RBC inventory. The conventional cryoprotectants (CPAs) have a lot of limitations, and there is an obvious need for novel, efficient, and biocompatible CPAs. Here, it is shown for the first time that the addition of dimethylglycine (DMG) improved the thawed RBC recovery from 11.55 ± 1.40% to 72.15 ± 1.22%. We found that DMG could reduce the mechanical damage by inhibiting ice formation and recrystallization during cryopreservation. DMG can also scavenge reactive oxygen species (ROS) and maintain endogenous antioxidant enzyme activities to decrease oxidative damage during cryopreservation. Furthermore, the properties of thawed RBCs were found to be similar to the fresh RBCs in the control. Finally, the technique for order performance by similarity to ideal solution (TOPSIS) was used to compare the performance of glycerol (Gly), hydroxyethyl starch (HES), and DMG in cryopreservation, and DMG exhibited the best efficiency. This work confirms the use of DMG as a novel CPA for cryopreservation of RBCs and may promote clinical transfusion therapy.

1. Introduction

Red blood cell (RBC) transfusion is regarded as a life-saving procedure, with the primary goal of maintaining tissue and organ oxygenation in patients suffering from severe bleeding or acute anemia [1]. The American Red Cross estimates that 29,000 units of RBCs are required every day in the USA [2]. Unfortunately, RBCs for transfusion have a limited shelf life (less than 42 days) after donation due to detrimental storage effects on morphological and biochemical properties [3,4], which leads to an undesired waste of 1.7 million units of blood in the USA [5]. Therefore, prolonging RBCs’ storage duration is essential for clinical transfusion.
Cryopreservation is the use of extremely low temperatures (−80 °C or −196 °C) to preserve living cells and tissues [6,7]. It can slow or stop the metabolism of the RBCs, thus greatly extending the storage time [8]. However, there are several problems with this approach. During cryopreservation, the freezing of water harms cells in two different ways: osmotic damage and mechanical damage. First, extracellular ice formation contributes to the efflux of water from cells, and thus the cells are damaged by excessive shrinkage, which is called osmotic damage. Second, lethal intracellular ice formation (IIF) induced by the trapped water during freezing and subsequent ice recrystallization during thawing cause mechanical damage to the cells [9,10]. In recent years, oxidative damage triggered by excessive reactive oxygen species (ROS) levels has received wide attention and developed into a significant research topic [11]. Multiple effects of ROS-induced damages to cellular biomolecules can be attributed to lipid peroxidation, DNA damage, and protein oxidation [12].
Therefore, cryoprotectants (CPAs) should be added to cells to minimize damage during cryopreservation [13]. Since the first discovery of glycerol (Gly) in 1949, CPAs have received great attention [14]. Currently, Gly is the only clinically licensed CPA for cryopreservation of RBCs [15]. However, its wide application is restricted due to the toxicity of Gly and the complex deglycerolization process. Cryopreservation practices for RBCs use 20–40 wt% Gly [16]. Such high concentrations of Gly cause RBCs to undergo negative morphological changes after cryopreservation, which will further affect RBCs’ function by reducing their deformability [17]. Multiple washing steps are required prior to transfusion, which takes 30–60 min per unit (475 mL) of blood [18]. Consequently, this process does not provide immediate access to blood, which is a problem in urgent situations requiring blood transfusions [19]. Hydroxyethyl starch (HES) is an alternative to Gly for the cryopreservation of RBCs because it is safer and less toxic than Gly [20,21]. However, HES is not an effective CPA. The thawed RBCs’ recovery is less than 40%, even at high concentrations of HES [22]. Many other CPAs have been explored over the years. They include trehalose [23], betaine [24], block copolymer worms [25], and polymeric mimics of antifreeze proteins [26], etc. However, very few have shown the same efficiency as Gly. Therefore, the study for novel, efficient, and non-toxic CPAs is still ongoing.
Dimethylglycine (DMG) is a methylated derivative of the amino acid glycine with the chemical formula (CH3)2NCH2COOH (Figure 1) [27,28]. The molecule, first reported in 1943, is a naturally occurring intermediate metabolite in plant and animal cells [29,30]. It can be used as an antioxidant in the food industry and as a pharmaceutical intermediate to synthesize various biochemical drugs in the pharmaceutical industry [31]. Nowadays, DMG has been widely used as a dietary supplement [32], an amino acid-based surfactant [33], and a source of glycine for glutathione synthesis to improve the antioxidant capacity in the body [34].
In the current study, we have explored the potential of DMG as a novel CPA in the cryopreservation of RBCs. DMG showed satisfactory thawed RBC recovery in cryopreservation. No significant difference was found between the DMG group and the Gly group. Then, we further found that DMG could mitigate mechanical and oxidative damages during cryopreservation. The membrane properties, protein activities, and metabolite levels of thawed RBCs were also well maintained. The technique for order performance by similarity to ideal solution (TOPSIS) analyzed the advantages of DMG versus Gly and HES. These studies presented an attractive alternative to conventional CPAs and showed potential to benefit patients in clinical applications of transfusion.

2. Results

2.1. The Good Biocompatibility of DMG

Currently, the widespread use of cryopreservation is hindered by the cytotoxicity of CPAs [35]. In this work, the biocompatibility was determined by measuring the RBC recovery after incubating in various solutions at 4 °C for 48 h [7]. As shown in Figure 2, the RBC recovery in 1–4% concentrations of DMG solutions was more than 90%, indicating DMG had good biocompatibility. However, high concentrations of DMG led to relatively high hemolysis. Furthermore, we discovered that the RBC recovery in the 20% Gly group was as low as 71.89 ± 4.02%. The severe hemolysis may be caused by high osmotic pressure. Used as a clinical plasma substitute for many years, HES has excellent biocompatibility for blood [36]. The RBC recovery in 13% HES was 98.54 ± 0.72%, which is consistent with HES’s good safety.

2.2. Satisfactory Recovery of Thawed RBCs Cryopreserved with DMG

After the biocompatibility test, we further explored the efficiency of three CPAs to cryopreserve RBCs. The thawed RBC recovery was positively associated with the concentration of DMG within a specific range, as shown in Figure 3. The optimal concentration of DMG was 4%, and the thawed RBC recovery was up to 72.15 ± 1.22%. There was no significant difference between 4% DMG solution and 20% Gly in the thawed RBC recovery. In comparison to 20% Gly and 4% DMG solutions, 13% HES showed a low thawed RBC recovery of 42.62 ± 3.47%, indicating its poor efficiency for cryopreservation alone.

2.3. Ability to Protect RBCs from Mechanical Damage

Ice recrystallization inhibition (IRI) activity of DMG is evaluated by splat assay [37]. With this assay, IRI activity can be quickly assessed by monitoring the size of ice under a polarizing microscope. In the PBS group (blank control), the size of the ice was the largest (Figure 4A), which would lead to severe mechanical damage to RBCs during cryopreservation. Conversely, at concentrations of 1% to 6%, DMG had a strong IRI activity that effectively inhibited the growth of ice crystals (Figure 4B–G). Data from splat assay are commonly presented as the mean largest grain size (MLGS) (Figure 4H). In the PBS group, the MLGS reached 111.90 ± 4.82 µm. However, the MLGS was significantly reduced to 93.34 ± 4.62 µm by adding 1% DMG (p < 0.001). With increasing DMG concentrations, MLGS became much smaller. The results demonstrated that DMG could inhibit ice recrystallization and protect RBCs from mechanical damage. Additional cryomicroscopic images of PBS and 4% DMG that highlight ice crystal growth are displayed in Figure S1.
Differential scanning calorimetry (DSC) was used to quantitatively calculate the amount of bound water in DMG during the freezing–thawing process. In Figure 4I, the pure water sample presented a larger endothermic peak area than the DMG sample, and the proportion of bound water in the 4% DMG group was 16.56%, suggesting that DMG could produce more bound water to reduce the ice content and damage.

2.4. Ability to Protect RBCs from Oxidative Damage

The 1,1-Diphenyl-2-picrylhydrazyl radical (DPPH) free radical scavenging method is a simple, rapid, and accurate way to measure antioxidant activity [38]. The DPPH free radical scavenging effect of the samples can be calculated as the Trolox equivalent’s antioxidant capacity [39]. The standard curve shows a good linear relationship between DPPH clearance and Trolox concentrations with R2 = 0.9996 (Figure S2). DMG had the highest antioxidant capacity, reaching 20.02 ± 0.14 µgTrolox/mL. The free radical scavenging activity of different samples was in the following order: DMG > HES > Gly. PBS was not detected (Figure 5A).
RBCs express enzymatic antioxidant defense systems to prevent and alleviate intracellular oxidative stress, including superoxide dismutase (SOD) and catalase (CAT) [40]. For SOD activity, the PBS group (14.29 ± 2.37 × 104 U/gHb), DMG group (16.00 ± 1.95 × 104 U/gHb), Gly group (15.72 ± 1.95 × 104 U/gHb), and HES group (20.41 ± 1.71 × 104 U/gHb) were all higher than the control group (10.15 ± 1.59 × 104 U/gHb) (Figure 5B). For CAT activity, the DMG group (30.86 ± 1.10 U/gHb), Gly (27.15 ± 1.66 U/gHb) and control group (29.11 ± 2.18 U/gHb) were similar (Figure 5C). Total CAT activity was found to be lowest in the PBS group (19.23 ± 1.67 U/gHb) and highest in the HES group (43.69 ± 3.95 U/gHb).
The oxidative damage on RBCs lipids and the effect of DMG were evaluated by measuring the level of malondialdehyde (MDA) [19]. Compared to the control group (3.16 ± 2.06 nmol/gHb), the results demonstrated that the DMG group (2.93 ± 2.73 nmol/gHb) had no effect on the lipid peroxidation level in RBCs after cryopreservation. In contrast, the PBS group (33.04 ± 4.27 nmol/gHb), Gly group (19.87 ± 0.73 nmol/gHb), and HES group (26.32 ± 3.86 nmol/gHb) induced significant lipid peroxidation (Figure 5D).

2.5. The Properties of Thawed RBCs

The properties of thawed RBCs were detected by the morphology, osmotic fragility, erythrocyte sedimentation rate (ESR), ATPase activities, and content of hemoglobin (Hb).
The normal morphology of RBCs is essential for their survival and oxygen-carrying capacity [41]. First, flow cytometry was used to evaluate the thawed RBCs’ morphology. In swollen RBCs, the size of forward scatter would increase, whereas in shrunken cells, the size of side scatter would increase. These analyses would show if cells are damaged in a manner that changes the shape of their surface membrane [18]. Compared to fresh RBCs (Figure 6A), the RBCs (Figure 6B) that were cryopreserved in 4% DMG showed similar profiles, suggesting their morphology is normal. For comparison, RBCs placed in a hypotonic solution of 0.7% NaCl (Figure 6C) became swollen due to water intake, and in a hypertonic solution of 2.9% NaCl (Figure 6D), RBCs shrank due to water loss, demonstrating how forward and side scatter profiles would change in response to osmotic stress. To further investigate the morphology of the RBCs, SEM analysis was performed. The fresh RBCs are normally biconcave discocytes. Many RBCs that were frozen with PBS presented acanthocytic shapes (Figure 6E), suggesting serious osmotic damage to the RBCs. Conversely, RBCs in the 4% DMG group remained regular shape (Figure 6F). Therefore, the 4% DMG solutions helped to maintain the morphology of RBCs during cryopreservation.
The ability of the cell membrane to protect structural integrity is assessed by the osmotic fragility of RBCs [42]. It should be noted that when thawed RBCs in the 20% Gly group were washed directly, the huge osmotic shock would lead to severe hemolysis. It was the reason we could not test their osmotic fragility. There was 50% hemolysis at 0.45–0.50% NaCl for fresh RBCs. The 50% hemolysis occurred at 0.60% NaCl for RBCs frozen in the 4% DMG solution and at 0.70–0.80% NaCl frozen in 13% HES, respectively (Figure 6G). Thus, although RBCs cryopreserved in 4% DMG did not have the same membrane stability as normal RBCs, their membrane stability was still superior to that of 13% HES.
ESR, one of the vital considerations of blood rheology, refers to the sedimentation velocity of RBCs in the blood. It fluctuates within a narrow range in normal RBCs and increases in many pathological states [41,43]. As shown in Figure 6H, there was no significant difference in ESR between the DMG group and the control group at 1 h, 4 h, 7 h, and 10 h. Na+/K+-ATPase and Ca2+/Mg2+-ATPase are two ATP-hydrolyzing enzymes that help maintain intracellular ion gradients. The stability of intracellular ion concentrations is important for stabilizing signal transduction and modulating cell metabolism [44]. The results showed that freezing the RBCs with 4% DMG did not alter the activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase (Figure 6I). Hb content represented oxygen carrying capacity [41], and there was no significant difference between the DMG group (19.62 ± 5.21 nmol/gHb) and the control group (21.88 ± 4.95 nmol/gHb) (Figure 6J).

2.6. Comparing CPAs by TOPSIS Model

TOPSIS is an effective method to deal with multiple attribute or multiple criteria decision-making problems in the real world. It is helpful for decision-makers to structure the problems that need to be resolved and to conduct analyses, comparisons, and rankings of the alternatives [45]. Hence, we used TOPSIS to quantitatively compare and assess the efficiency of Gly, HES, and DMG. The initial decision matrix was formed using three relevant criteria for CPAs, including the recovery, concentration, and biocompatibility of the thawed RBCs, as listed in Table 1. The recovery and biocompatibility of the thawed RBCs were regarded as benefit attributes, whereas concentration was the cost attribute. The results of the TOPSIS model, including the relative closeness and rank of CPAs, are displayed in Table 2. DMG had the highest closeness coefficient of 0.871, Gly and HES were 0.319 and 0.212, respectively.

3. Discussion

The cryopreservation of RBCs is a life-saving method that facilitates rapid access to blood samples for emergencies. However, the freeze–thaw conditions for this process are less than ideal, resulting in a low supply of RBCs. In cryopreservation, mechanical damage caused by ice formation and growth severely destroys the plasma membrane, leading to RBC death [46]. The interaction of water molecules is precisely correlated with ice formation and growth. In this study, DSC results indicated DMG could increase the ratio of bound water and inhibit the formation of ice crystals during freezing through its great water binding capacity. DMG could also greatly inhibit ice recrystallization during thawing. These effects reduced the mechanical damage to RBCs caused by large amounts of ice.
Apart from mechanical damage, oxidative damage caused by ROS is the other cause of cellular damage during cryopreservation [12]. We have investigated DMG as a protectant to prevent oxidative damage to RBCs during cryopreservation. DMG showed strong antioxidant DPPH radical scavenging activity. Moreover, the activities of endogenous antioxidant enzymes could be maintained by DMG. SOD and CAT are important enzymes that protect cells from damage caused by free radicals and ROS [47]. SOD activity in RBCs increased significantly during cryopreservation, which might be due to the fact that the stimulation of SOD activity could reduce oxidative damage and play a protective role in protecting RBCs. CAT was damaged during cryopreservation, but its activity was maintained by the addition of DMG. MDA is a lipid peroxidation product, and its accumulation has been used as an important indicator of oxidative damage brought on by ROS. The results demonstrated that DMG had no impact on the lipid peroxidation level in RBCs after cryopreservation. In contrast, both Gly and HES showed similar oxidative damage, which was seen as a higher level of lipid peroxidation after cryopreservation.
Based on the discussion presented above, the proposed mechanism of the cryoprotective effects on RBCs of DMG during cryopreservation is shown in Figure 7.
Besides recovery, the properties of thawed RBCs play a key role in transfusion therapy. We evaluated the morphology of RBCs by flow cytometry and SEM analysis, osmotic fragility, ESR, ATPase activities, and content of Hb. First, the normal morphology of RBCs is critical to their survival and function. Second, the osmotic fragility reflects the membrane stability of RBCs. Third, ESR is one of the important parameters of blood rheology. Fourth, Na+/K+-ATPase and Ca2+/Mg2+-ATPase are two ATP hydrolases that contribute to the maintenance of intracellular ionic gradients. Fifth, Hb is the main oxygen-carrying protein in RBCs. The findings confirmed that the properties of RBCs cryopreserved in DMG were well maintained, suggesting that these RBCs might be used safely.
We have used the TOPSIS model for analysis in order to quantitatively compare the performance of DMG, Gly, and HES further. The recovery, concentration, and biocompatibility of the thawed RBCs were taken into consideration to contribute to the comparison of three CPAS in the cryopreservation of RBCs. The results displayed that DMG had the best efficiency under the three criteria and showed great promise in cryopreservation, but it remains to be further investigated whether DMG can replace Gly or HES in clinical transfusion therapy.
In conclusion, we showed that DMG could work as a novel CPA and achieve a high recovery of RBCs during cryopreservation. DMG possessed a strong ability to inhibit ice recrystallization, increase the ratio of bound water, and reduce oxidative damage. After cryopreservation, the behaviors of the thawed RBCs, including their morphology, osmotic fragility, ESR, ATPase activities, and content of Hb, were found to be similar to those of the normal cells, showing that their properties were not affected. In addition, TOPSIS model analysis demonstrated that DMG had good performance in the cryopreservation of RBCs. This work offers an attractive alternative to conventional CPAs and holds great promise for the current clinical practice of RBCs.

4. Materials and Methods

4.1. Cryoprotective Solutions

Cryoprotective solutions were prepared with 20% glycerol (Sinopharm, Shanghai, China), 13% HES (Macklin, Shanghai, China), and 1%, 2%, 3%, 4%, 5%, and 6% DMG (Aladdin, Shanghai, China). All solutions were formulated with PBS (Wuhan Servicebio Technology Co., Ltd., Wuhan, China).

4.2. RBCs Preparation

The sheep RBCs were bought from Hongquan (Guangzhou, China). RBCs were washed with PBS in a 15 mL centrifuge tube by centrifugation (1980× g, 3 min). Then, the supernatant was removed. To obtain washed RBCs, the above operation was repeated twice.

4.3. Biocompatibility Test

To test the biocompatibility, equal amounts of washed RBCs (20 μL) were incubated in 1 mL cryoprotective solutions at 4 °C for 48 h and resuspended every 24 h. After 48 h, RBCs were collected to assess survival rates. Then, RBCs were centrifuged at 1980× g for 3 min. The supernatant was measured the absorbance using a microplate reader (Tecan Infinite M200 PRO, Austria) at 450 nm wavelength. A positive control was established by measuring the absorbance of the supernatant with 20 μL fresh RBCs dissolved in 1 mL deionized water, whereas a negative control was determined by adding 20 μL fresh RBCs to 1 mL PBS. The RBC recovery can be calculated using the following equation [15]:
Hemolysis   ( % ) = A A 0 A 1 A 0 × 100 %
Recovery   ( % ) = 100 % Hemolysis   ( % )
where A is the absorbance of the measured sample and A0 and A1 are the negative control and positive control, respectively.

4.4. Cryopreservation of RBCs

Washed RBCs (20 μL) were suspended in 1 mL PBS or cryoprotective solutions as the control group and the experimental group for 20–30 min. The samples were frozen by directly immersing them in liquid nitrogen in cryogenic vials (Wuhan Servicebio Technology Co., Ltd.) for at least 20 min. Then, cells were instantly thawed in a 37 °C water bath for recovery. The thawed RBC recovery can be calculated as described above in 4.3.

4.5. Splat Assay

In 1986, the splat assay was established by Knight and Dumani [48]. PBS and DMG samples of different concentrations (1%, 2%, 3%, 4%, 5%, and 6%) were prepared by the above method. A 6μL droplet is dropped ~1.4 m onto a pre-cooled coverslip. The coverslip is immediately transferred to a N2 cooled cryostage (Huitong, LTM-190H, Shanghai, China) and annealed at −8 °C for 30 min. Afterwards, the wafers are imaged using a polarizing microscope (Huitong, XPF-550, Shanghai, China). The ten largest crystals’ sizes were measured.

4.6. DSC Test

The water binding capacity of DMG was investigated using DSC. The samples (10 mg) were sealed into crucibles and transferred to the calorimeter sample chamber (TA Q2000, DSC2500, USA), then cooled to −40 °C from 30 °C at a rate of 10 °C/min and heated to 10 °C at a rate of 2 °C/min. The heat flow (w/g) was monitored. The total water content (wtc), freezing water content (wf), and bound water content (wb) could be calculated according to the following equations [24]:
w tc = m w / m
w f = Δ H / Δ H w
w b = w tc w f
where mw and m are the water mass and the total mass of each sample, and ∆H and ∆Hw stand for the melting enthalpies of 4% DMG and pure water, respectively, which are measured by DSC during the heating process.

4.7. Antioxidant Assays

The antioxidant activity of DMG was estimated using the DPPH free radical scavenging method (Nanjing Jiancheng, A153-1-1, Nanjing, China). Briefly, 400 µL sample extract, or standard, and 600 µL of DPPH reagent were added and mixed vigorously. The reaction mixture was kept at room temperature for 30 min in the dark, and the discoloration of DPPH was obtained against a blank at 517 nm using the UV–Vis spectrophotometer (UV-2600, Shimadzu Europe).
Total SOD was tested by the xanthine oxidase method; the SOD activity was determined using assay kits (Nanjing Jiancheng, A001-1-1, China).
CAT activity was assessed using a commercial kit (Nanjing Jiancheng, A007-2-1, China) and quantified by analyzing the absorbance change rate of hydrogen peroxide at 240 nm [49].
The level of lipid peroxidation was quantified using 50 μL thawed RBCs lysates by the formation of the amount of malondialdehyde-thiobarbituric acid adduct in an acidic condition at 95 °C for 40 min. The absorbance of the samples was measured at 532 nm using the UV–Vis spectrophotometer (Nanjing Jiancheng, A003-1-1, China).
All the measurement methods are provided in the manufacturers’ instructions in detail.

4.8. Flow Cytometry

The RBC morphology was assessed by flow cytometry. Samples were made by diluting fresh RBCs in 0.9% NaCl, 2.9% NaCl, and 0.7% NaCl solutions. The experimental group consisted of post-freeze–thaw RBCs in 4% DMG solution. All samples were tested using the BD LSRFortessa™ Cell Analyzer.

4.9. SEM Analysis

The thawed RBCs were fixed for 12 h with 2.5% glutaraldehyde and then washed three times with PBS. Then, the RBCs were fixed once more in 1% osmic acid for 1–2 h and washed with PBS three times again. The fixed samples were dehydrated for 15 min in each gradient of 30%, 50%, 70%, 80%, 90%, and 95% alcohol before being treated twice with 100% alcohol for 20 min each. Subsequently, the RBCs were exposed to a mixture of alcohol and isoamyl acetate (v/v = 1/1) for 30 min, followed by exposure to pure isoamyl acetate for 1 h or left overnight. Next, the RBCs were dried and metalized with gold in succession. Finally, the images of RBCs were obtained using a scanning electron microscope (Hitachi, SU8010, Tokyo, Japan).

4.10. Osmotic Fragility

The osmotic fragility of the RBCs was determined using a stepwise dilution of 1.0% NaCl ranging from 0.1–1.0%. The thawed cells were washed twice with 0.9% NaCl at 4000 rpm to remove cryopreserve solutions. Washed RBCs (7.5 μL) were diluted 500 μL different osmotic fragility solutions at room temperature for 30 min. Afterward, the samples were centrifuged at 1980× g for 3 min. The absorbance of the supernatant was tested at 450 nm and the hemolysis percent of RBCs was calculated.

4.11. ESR Test

The erythrocyte sedimentation rate can be measured using the Westergren method, which is how quickly RBCs sink to the bottom of a blood sample [50]. After cryopreservation, a 50 μL aliquot of RBCs was added to 2 mL PBS. After being moved to a Westergren tube, the samples’ level was adjusted to the 0-scale point. The samples’ ESR was measured at 1 h, 4 h, 7 h, and 10 h.

4.12. ATPase Activities Assays

In accordance with the manufacturer’s instructions (Nanjing Jiancheng, A070-6-3, China), enzymatic activities assays were carried out using fresh RBCs and thawed RBCs. The RBCs were washed with 0.9% NaCl at 4000 rpm for 3 min. After removing the supernatant, DI water was added to acquire the lysis of RBCs. For the assessment of Na+/K+-ATPase and Ca2+/Mg2+-ATPase activities, the lysis of RBCs was treated with the reaction mixtures at 37 °C for 10 min. Then two reactions were stopped. The supernatant was collected to detect concentrations of inorganic phosphorus after centrifugation at 1516× g for 10 min [44].

4.13. Content of Hb

The concentration of Hb (mgHb/mL) from fresh and thawed RBCs in 4% DMG was measured by the HICN colorimetric method (Nanjing Jiancheng, C021-1-1, China). A hemocytometer was used to calculate the number of RBCs per milliliter. As a result, the content of Hb in RBCs (mgHb/109 RBCs) could be acquired.

4.14. TOPSIS

The performance of DMG, Gly, and HES in cryopreservation was assessed using the TOPSIS model [51]. The following summarized the TOPSIS method’s application process.
Stage 1. A decision matrix was created. The decision matrix X, consisting of m alternatives and n criteria, was formed by Equation (6).
X = ( χ i j ) m × n = ( χ 11 χ 12 χ 1 n χ 21 χ 22 χ 2 n χ m 1 χ m 2 χ m n )
Stage 2. A normalized decision matrix was formed. Equations (7)–(9) normalized each element xij into a corresponding element Sij in the matrix S.
S = ( s i j ) m × n = ( s 11 s 12 s 1 n s 21 s 22 s 2 n s m 1 s m 2 s m n )
where
S ij = χ ij i = 1 m ( χ ij ) 2 ,   for   benefit   attribute   χ ij
S ij = χ j max χ ij i = 1 m ( χ j max χ ij ) 2 ,   for   cost   attribute   χ ij ,   where   χ j max = max m i   x ij
Stage 3. The positive ideal solutions (PIS) Sj+ and negative ideal solutions (NIS) Sj sets were constituted.
S j + = max i = 1 m   S ij
S j = min i = 1 m   S ij
Stage 4. Separation measures were calculated.
In the TOPSIS method, positive ideal separation (D+) and negative ideal separation (D) were the two separation measures for each alternative. The distance of the alternative to the PIS (D+)/NIS (D) was determined based on Equations (12) and (13), respectively. In these calculations, the Euclidean distance method was applied.
D i + = j = 1 n ( S j + s i j ) 2
D i = j = 1 n ( S j s i j ) 2
Stage 5. Relative closeness to the ideal solution was calculated.
Equation (14) below calculated the relative closeness to the PIS of each alternative using Di+ and Di. The alternative that is nearest to the PIS is determined to be the most suitable decision alternative.
C i = D i D i + D i +

4.15. Statistical Analysis

Statistical analyses were performed by GraphPad Prism 9.4.1 (GraphPad Software, San Diego, CA, USA). The results of the RBC experiments are presented as the mean ± standard deviation of three independent experiments. Data were analyzed statistically by a one-way analysis of variance (ANOVA), and Tukey’s post-hoc test was used for pairwise comparisons of different groups. A p-value lower than 0.05 was considered statistically significant. * Indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.

Supplementary Materials

The following are available online at: https://www.mdpi.com/article/10.3390/ijms24076696/s1.

Author Contributions

Conceptualization, Y.H. (Yuying Hu) and X.L.; methodology, Y.H. (Yuying Hu) and X.L.; software, X.C.; validation, J.C.; investigation, J.X. and W.Z.; resources, Y.H. (Yongju He) and S.T.; data curation, Y.H. (Yuying Hu); writing-original draft preparation, Y.H. (Yuying Hu) and X.L.; writing-review and editing, M.D.E.; visualization, R.Z.; supervision, S.T.; project administration, S.T.; funding acquisition, Y.H. (Yuying Hu), X.L., J.X., R.Z. and S.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Postgraduate Innovative Project of Central South University.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All experimental data within the article are available from the corresponding author upon reasonable request.

Acknowledgments

We would like to thank Zhou Yuan from Shiyanjia Lab (www.shiyanjia.com) for the SEM analysis. Figure 7 was created with BioRender.com.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Barshtein, G.; Arbell, D.; Livshits, L.; Gural, A. Is It Possible to Reverse the Storage-Induced Lesion of Red Blood Cells? Front. Physiol. 2018, 9, 914. [Google Scholar] [CrossRef] [PubMed]
  2. Cross, T.A.R. Facts about Blood Needs. 2022. Available online: https://www.redcrossblood.org/donate-blood/how-to-donate/how-blood-donations-help/blood-needs-blood-supply.html (accessed on 1 December 2022).
  3. Koch, C.G.; Figueroa, P.I.; Li, L.; Sabik, J.F.; Mihaljevic, T.; Blackstone, E.H. Red Blood Cell Storage: How Long Is Too Long? Ann. Thorac. Surg. 2013, 96, 1894–1899. [Google Scholar] [CrossRef] [PubMed]
  4. Sut, C.; Tariket, S.; Chou, M.L.; Garraud, O.; Laradi, S.; Hamzeh-Cognasse, H.; Seghatchian, J.; Burnouf, T.; Cognasse, F. Duration of red blood cell storage and inflammatory marker generation. Blood Transfus. 2017, 15, 145–152. [Google Scholar]
  5. Zhai, H.; Yang, J.; Zhang, J.; Pan, C.; Cai, N.; Zhu, Y.; Zhang, L. Natural zwitterionic l-Carnitine as efficient cryoprotectant for solvent-free cell cryopreservation. Biochem. Biophys. Res. Commun. 2017, 489, 76–82. [Google Scholar] [CrossRef] [PubMed]
  6. Pegg, D.E. Principles of cryopreservation. Methods Mol. Biol. 2007, 368, 39–57. [Google Scholar] [PubMed]
  7. Dou, M.; Lu, C.; Sun, Z.; Rao, W. Natural cryoprotectants combinations of l-proline and trehalose for red blood cells cryopreservation. Cryobiology 2019, 91, 23–29. [Google Scholar] [CrossRef]
  8. Mazur, P. Cryobiology: The freezing of biological systems. Science 1970, 168, 939–949. [Google Scholar] [CrossRef] [PubMed]
  9. Chang, T.; Zhao, G. Ice inhibition for cryopreservation: Materials, strategies, and challenges. Adv. Sci. 2021, 8, 2002425. [Google Scholar] [CrossRef]
  10. Yang, J.; Pan, C.; Zhang, J.; Sui, X.; Zhu, Y.; Wen, C.; Zhang, L. Exploring the Potential of Biocompatible Osmoprotectants as Highly Efficient Cryoprotectants. ACS Appl. Mater. Interfaces 2017, 9, 42516–42524. [Google Scholar] [CrossRef]
  11. Cao, B.; Qin, J.; Pan, B.; Qazi, I.H.; Ye, J.; Fang, Y.; Zhou, G. Oxidative Stress and Oocyte Cryopreservation: Recent Advances in Mitigation Strategies Involving Antioxidants. Cells 2022, 11, 3573. [Google Scholar] [CrossRef]
  12. Len, J.S.; Koh, W.S.D.; Tan, S.-X. The roles of reactive oxygen species and antioxidants in cryopreservation. Biosci. Rep. 2019, 39, BSR20191601. [Google Scholar] [CrossRef] [Green Version]
  13. Raju, R.; Bryant, S.J.; Wilkinson, B.L.; Bryant, G. The need for novel cryoprotectants and cryopreservation protocols: Insights into the importance of biophysical investigation and cell permeability. Biochim. Biophys. Acta Gen. Subj. 2021, 1865, 129749. [Google Scholar] [CrossRef]
  14. Polge, C.; Smith, A.U.; Parkes, A.S. Revival of spermatozoa after vitrification and dehydration at low temperatures. Nature 1949, 164, 666. [Google Scholar] [CrossRef] [PubMed]
  15. Shen, L.; Guo, X.; Ouyang, X.; Huang, Y.; Gao, D.; Zhao, G. Fine-tuned Dehydration by Trehalose Enables Cryopreservation of RBCs with Unusually Low Concentrations of Glycerol. J. Mater. Chem. 2021, 9, 295–306. [Google Scholar] [CrossRef] [PubMed]
  16. Chaudhari, C.N. Frozen Red Blood Cells in Transfusion. Med. J. Armed Forces India 2009, 65, 55–58. [Google Scholar] [CrossRef] [Green Version]
  17. Asghar, W.; El Assal, R.; Shafiee, H.; Anchan, R.M.; Demirci, U. Preserving human cells for regenerative, reproductive, and transfusion medicine. Biotechnol. J. 2014, 9, 895–903. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Murray, A.; Congdon, T.R.; Tomás, R.M.F.; Kilbride, P.; Gibson, M.I. Red Blood Cell Cryopreservation with Minimal Post-Thaw Lysis Enabled by a Synergistic Combination of a Cryoprotecting Polyampholyte with DMSO/Trehalose. Biomacromolecules 2022, 23, 467–477. [Google Scholar] [CrossRef]
  19. Alotaibi, N.A.; Slater, N.K.; Rahmoune, H. Salidroside as a Novel Protective Agent to Improve Red Blood Cell Cryopreservation. PLoS ONE 2016, 11, e0162748. [Google Scholar] [CrossRef] [Green Version]
  20. Thomas, M.J.G.; Parry, E.S.; Nash, S.G.; Bell, S.H. A method for the cryopreservation of red blood cells using hydroxyethyl starch as a cryoprotectant. Transfus. Sci. 1996, 17, 385–396. [Google Scholar] [CrossRef] [PubMed]
  21. Sun, Y.; Maltseva, D.; Liu, J.; Hooker, T., II; Mailänder, V.; Ramløv, H.; DeVries, A.L.; Bonn, M.; Meister, K. Ice Recrystallization Inhibition Is Insufficient to Explain Cryopreservation Abilities of Antifreeze Proteins. Biomacromolecules 2022, 23, 1214–1220. [Google Scholar] [CrossRef]
  22. Zhu, W.; Guo, J.; Agola, J.O.; Croissant, J.G.; Wang, Z.; Shang, J.; Coker, E.; Motevalli, B.; Zimpel, A.; Wuttke, S.; et al. Metal–Organic Framework Nanoparticle-Assisted Cryopreservation of Red Blood Cells. J. Am. Chem. Soc. 2019, 141, 7789–7796. [Google Scholar] [CrossRef]
  23. Stefanic, M.; Ward, K.; Tawfik, H.; Seemann, R.; Baulin, V.; Guo, Y.; Fleury, J.B.; Drouet, C. Apatite nanoparticles strongly improve red blood cell cryopreservation by mediating trehalose delivery via enhanced membrane permeation. Biomaterials 2017, 140, 138–149. [Google Scholar] [CrossRef] [Green Version]
  24. Sui, X.; Wen, C.; Yang, J.; Guo, H.; Zhao, W.; Li, Q.; Zhang, J.; Zhu, Y.; Zhang, L. Betaine combined with membrane stabilizers enables solvent-free whole blood cryopreservation and one-step cryoprotectant removal. ACS Biomater. Sci. Eng. 2018, 5, 1083–1091. [Google Scholar] [CrossRef] [PubMed]
  25. Mitchell, D.E.; Lovett, J.R.; Armes, S.P.; Gibson, M.I. Combining Biomimetic Block Copolymer Worms with an Ice-Inhibiting Polymer for the Solvent-Free Cryopreservation of Red Blood Cells. Angew. Chem. Int. Ed. Engl. 2016, 55, 2801–2804. [Google Scholar] [CrossRef]
  26. Deller, R.C.; Vatish, M.; Mitchell, D.A.; Gibson, M.I. Synthetic polymers enable non-vitreous cellular cryopreservation by reducing ice crystal growth during thawing. Nat. Commun. 2014, 5, 3244. [Google Scholar] [CrossRef] [Green Version]
  27. Kalmar, I.D.; Verstegen, M.W.A.; Maenner, K.; Zentek, J.; Meulemans, G.; Janssens, G.P.J. Tolerance and safety evaluation of N,N-dimethylglycine, a naturally occurring organic compound, as a feed additive in broiler diets. Br. J. Nutr. 2012, 107, 1635–1644. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Hsieh, C.-P.; Chen, S.-T.; Lee, M.-Y.; Huang, C.-M.; Chen, H.-H.; Chan, M.-H. N,N-dimethylglycine Protects Behavioral Disturbances and Synaptic Deficits Induced by Repeated Ketamine Exposure in Mice. Neuroscience 2021, 472, 128–137. [Google Scholar] [CrossRef] [PubMed]
  29. Tonda, M.E.; Hart, L.L. N,N dimethylglycine and L-carnitine as performance enhancers in athletes. Ann. Pharmacother. 1992, 26, 935–937. [Google Scholar] [PubMed]
  30. Currell, K.; Syed, A.; Dziedzic, C.E.; King, D.S.; Spriet, L.L.; Collins, J.; Castell, L.M.; Stear, S.J.; Burke, L.M. A–Z of nutritional supplements: Dietary supplements, sports nutrition foods and ergogenic aids for health and performance—Part 12. Br. J. Sports Med. 2010, 44, 905. [Google Scholar] [CrossRef] [Green Version]
  31. Zheng, Y.; Jin, Y.; Zhang, N.; Wang, D.; Yang, Y.; Zhang, M.; Wang, G.; Lee, S.; Qu, W. Recovery of N,N-dimethylglycine (DMG) from dimethylglycine hydrochloride by bipolar membrane electrodialysis. Chem. Eng. Process. Process Intensif. 2022, 176, 108943. [Google Scholar] [CrossRef]
  32. Wolfsegger, T.; Böck, K.; Schimetta, W.; von Oertzen, T.J.; Assar, H. N,N-Dimethylglycine in patients with progressive multiple sclerosis: Result of a pilot double-blind, placebo, controlled randomized clinical trial. Neurol. Res. Pract. 2021, 3, 29. [Google Scholar] [CrossRef] [PubMed]
  33. Bai, K.; Xu, W.; Zhang, J.; Kou, T.; Niu, Y.; Wan, X.; Zhang, L.; Wang, C.; Wang, T. Assessment of Free Radical Scavenging Activity of Dimethylglycine Sodium Salt and Its Role in Providing Protection against Lipopolysaccharide-Induced Oxidative Stress in Mice. PLoS ONE 2016, 11, e0155393. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Friesen, R.W.; Novak, E.M.; Hasman, D.; Innis, S.M. Relationship of dimethylglycine, choline, and betaine with oxoproline in plasma of pregnant women and their newborn infants. J. Nutr. 2007, 137, 2641–2646. [Google Scholar] [CrossRef] [Green Version]
  35. Horváth, S. Cytotoxicity of drugs and diverse chemical agents to cell cultures. Toxicology 1980, 16, 59–66. [Google Scholar] [CrossRef]
  36. Wang, H.; Hu, H.; Yang, H.; Li, Z. Hydroxyethyl starch based smart nanomedicine. RSC Adv. 2021, 11, 3226–3240. [Google Scholar] [CrossRef]
  37. Biggs, C.I.; Stubbs, C.; Graham, B.; Fayter, A.E.R.; Hasan, M.; Gibson, M.I. Mimicking the Ice Recrystallization Activity of Biological Antifreezes. When is a New Polymer “Active”? Macromol. Biosci. 2019, 19, 1900082. [Google Scholar] [CrossRef] [Green Version]
  38. Payum, T.; Das, A.K.; Shankar, R.; Tamuly, C.; Hazarika, M. Antioxidant Potential of Solanum spirale Shoot and Berry: A Medicinal Food Plant Used in Arunachal Pradesh. Int. J. PharmTech Res. 2015, 5, 307–314. [Google Scholar]
  39. Liao, H.; Dong, W.; Shi, X.; Liu, H.; Yuan, K. Analysis and comparison of the active components and antioxidant activities of extracts from Abelmoschus esculentus L. Pharmacogn. Mag. 2012, 8, 156–161. [Google Scholar] [PubMed] [Green Version]
  40. Skrzep-Poloczek, B.; Poloczek, J.; Chełmecka, E.; Dulska, A.; Romuk, E.; Idzik, M.; Kazura, W.; Nabrdalik, K.; Gumprecht, J.; Jochem, J.; et al. The Oxidative Stress Markers in the Erythrocytes and Heart Muscle of Obese Rats: Relate to a High-Fat Diet but Not to DJOS Bariatric Surgery. Antioxidants 2020, 9, 183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Wang, Y.; Yang, P.; Yan, Z.; Liu, Z.; Ma, Q.; Zhang, Z.; Wang, Y.; Su, Y. The Relationship between Erythrocytes and Diabetes Mellitus. J. Diabetes Res. 2021, 2021, 6656062. [Google Scholar] [CrossRef] [PubMed]
  42. Bautista, M.L.; Altaf, W.; Lall, R.; Wapnir, R.A. Cord blood red cell osmotic fragility: A comparison between preterm and full-term newborn infants. Early Hum. Dev. 2003, 72, 37–46. [Google Scholar] [CrossRef] [PubMed]
  43. Kang, Y.J. Microfluidic-Based Measurement Method of Red Blood Cell Aggregation under Hematocrit Variations. Sensors 2017, 17, 2037. [Google Scholar] [CrossRef] [Green Version]
  44. Ji, L.; Chauhan, A.; Brown, W.T.; Chauhan, V. Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individuals. Life Sci. 2009, 85, 788–793. [Google Scholar] [CrossRef] [Green Version]
  45. Shih, H.-S.; Shyur, H.-J.; Lee, E.S. An extension of TOPSIS for group decision making. Math. Comput. Model. 2007, 45, 801–813. [Google Scholar] [CrossRef]
  46. Tian, Y.; Sun, D.-W.; Xu, L.; Fan, T.-H.; Zhang, S.-T.; Zhu, Z. Bioinspired Cryoprotectants Enabled by Binary Natural Deep Eutectic Solvents for Sustainable and Green Cryopreservation. ACS Sustain. Chem. Eng. 2022, 10, 7677–7691. [Google Scholar] [CrossRef]
  47. Uchida, M.; Teranishi, H.; Aoshima, K.; Katoh, T.; Kasuya, M.; Inadera, H. Reduction of erythrocyte catalase and superoxide dismutase activities in male inhabitants of a cadmium-polluted area in Jinzu river basin, Japan. Toxicol. Lett. 2004, 151, 451–457. [Google Scholar] [CrossRef]
  48. Knight, C.A.; Duman, J.G. Inhibition of recrystallization of ice by insect thermal hysteresis proteins: A possible cryoprotective role. Cryobiology 1986, 23, 256–262. [Google Scholar] [CrossRef]
  49. Zhang, J.-Q.; Shen, M.; Zhu, C.-C.; Yu, F.-X.; Liu, Z.-Q.; Ally, N.; Sun, S.-C.; Li, K.; Liu, H.-L. 3-Nitropropionic Acid Induces Ovarian Oxidative Stress and Impairs Follicle in Mouse. PLoS ONE 2014, 9, e86589. [Google Scholar] [CrossRef] [PubMed]
  50. Happe, M.R.; Battafarano, D.F.; Dooley, D.P.; Rennie, T.A.; Murphy, F.T.; Casey, T.J.; Ward, J.A. Validation of the Diesse Mini-Ves Erythrocyte Sedimentation Rate (ESR) Analyzer Using the Westergren ESR Method in Patients With Systemic Inflammatory Conditions. Am. J. Clin. Pathol. 2002, 118, 14–17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Miç, P.; Antmen, Z.F. A Decision-Making Model Based on TOPSIS, WASPAS, and MULTIMOORA Methods for University Location Selection Problem. SAGE Open 2021, 11, 21582440211040115. [Google Scholar] [CrossRef]
Figure 1. The 2D (A) and 3D (B) molecular structure of DMG.
Figure 1. The 2D (A) and 3D (B) molecular structure of DMG.
Ijms 24 06696 g001
Figure 2. Biocompatibility test. The concentrations of Gly and HES were 20% and 13%, respectively. *** p < 0.001.
Figure 2. Biocompatibility test. The concentrations of Gly and HES were 20% and 13%, respectively. *** p < 0.001.
Ijms 24 06696 g002
Figure 3. Thawed RBC recovery. The concentrations of Gly and HES were 20% and 13%, respectively. *** p < 0.001.
Figure 3. Thawed RBC recovery. The concentrations of Gly and HES were 20% and 13%, respectively. *** p < 0.001.
Ijms 24 06696 g003
Figure 4. Ability to reduce mechanical damage. The representative images of ice crystals in (A) PBS, (B) 1% DMG, (C) 2% DMG, (D) 3% DMG, (E) 4% DMG, (F) 5% DMG, and (G) 6% DMG. (H) Quantitative analysis of IRI activity through mean largest grain sizes (MLGS). (I) The heat flow of water and 4% DMG during the melting process. Scale bar = 10 µm. *** p < 0.001.
Figure 4. Ability to reduce mechanical damage. The representative images of ice crystals in (A) PBS, (B) 1% DMG, (C) 2% DMG, (D) 3% DMG, (E) 4% DMG, (F) 5% DMG, and (G) 6% DMG. (H) Quantitative analysis of IRI activity through mean largest grain sizes (MLGS). (I) The heat flow of water and 4% DMG during the melting process. Scale bar = 10 µm. *** p < 0.001.
Ijms 24 06696 g004
Figure 5. Ability to counter oxidative damage. (A) The antioxidant capacity was measured by the DPPH assay. The SOD (B) and CAT (C) activities of RBCs in different groups. (D) The content of MDA. The fresh RBCs without cryopreservation were selected as the control group. The concentrations of Gly, DMG, and HES were 20%, 4%, and 13%, respectively. Data are presented as the mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 5. Ability to counter oxidative damage. (A) The antioxidant capacity was measured by the DPPH assay. The SOD (B) and CAT (C) activities of RBCs in different groups. (D) The content of MDA. The fresh RBCs without cryopreservation were selected as the control group. The concentrations of Gly, DMG, and HES were 20%, 4%, and 13%, respectively. Data are presented as the mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.
Ijms 24 06696 g005
Figure 6. The properties of thawed RBCs after cryopreservation. Flow cytometry plots showed the forward scatter and side scatter of fresh RBCs (A) and post-freeze–thaw RBCs in DMG solution (B). For (A,B), RBCs were maintained in an isotonic environment so that they neither shrank nor swelled. For comparison, fresh RBCs placed in hypotonic 0.7% NaCl swelled due to the intake of water (C). In hypertonic 2.9% NaCl, fresh RBCs shrank due to loss of water (D). The representative SEM images of thawed RBCs incubated in PBS (E) and DMG (F). Osmotic fragility curves (G) of RBCs at different solutions. The ESR (H), ATPase activities (I), and content of Hb (J) of thawed RBCs in the control group and DMG group. The concentrations of DMG and HES were 4% and 13%, respectively. The fresh RBCs without cryopreservation were selected as the control group. Data are presented as the mean ± SD. Erythrocyte sedimentation rate (ESR), hemoglobin (Hb).
Figure 6. The properties of thawed RBCs after cryopreservation. Flow cytometry plots showed the forward scatter and side scatter of fresh RBCs (A) and post-freeze–thaw RBCs in DMG solution (B). For (A,B), RBCs were maintained in an isotonic environment so that they neither shrank nor swelled. For comparison, fresh RBCs placed in hypotonic 0.7% NaCl swelled due to the intake of water (C). In hypertonic 2.9% NaCl, fresh RBCs shrank due to loss of water (D). The representative SEM images of thawed RBCs incubated in PBS (E) and DMG (F). Osmotic fragility curves (G) of RBCs at different solutions. The ESR (H), ATPase activities (I), and content of Hb (J) of thawed RBCs in the control group and DMG group. The concentrations of DMG and HES were 4% and 13%, respectively. The fresh RBCs without cryopreservation were selected as the control group. Data are presented as the mean ± SD. Erythrocyte sedimentation rate (ESR), hemoglobin (Hb).
Ijms 24 06696 g006
Figure 7. The proposed mechanism of DMG during cryopreservation.
Figure 7. The proposed mechanism of DMG during cryopreservation.
Ijms 24 06696 g007
Table 1. Three alternative CPAs and three criteria.
Table 1. Three alternative CPAs and three criteria.
Types of CPAsConcentration (%wt)Thawed RBCs Recovery
(%)
Biocompatibility
(%)
Gly2085.9471.89
HES1342.6298.54
DMG472.1593.99
Table 2. The relative closeness and rank by TOPSIS.
Table 2. The relative closeness and rank by TOPSIS.
Types of CPAsRelative ClosenessRank
Gly0.3192
HES0.2123
DMG0.8711
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hu, Y.; Liu, X.; Ekpo, M.D.; Chen, J.; Chen, X.; Zhang, W.; Zhao, R.; Xie, J.; He, Y.; Tan, S. Dimethylglycine Can Enhance the Cryopreservation of Red Blood Cells by Reducing Ice Formation and Oxidative Damage. Int. J. Mol. Sci. 2023, 24, 6696. https://doi.org/10.3390/ijms24076696

AMA Style

Hu Y, Liu X, Ekpo MD, Chen J, Chen X, Zhang W, Zhao R, Xie J, He Y, Tan S. Dimethylglycine Can Enhance the Cryopreservation of Red Blood Cells by Reducing Ice Formation and Oxidative Damage. International Journal of Molecular Sciences. 2023; 24(7):6696. https://doi.org/10.3390/ijms24076696

Chicago/Turabian Style

Hu, Yuying, Xiangjian Liu, Marlene Davis Ekpo, Jiangming Chen, Xiaoxiao Chen, Wenqian Zhang, Rui Zhao, Jingxian Xie, Yongju He, and Songwen Tan. 2023. "Dimethylglycine Can Enhance the Cryopreservation of Red Blood Cells by Reducing Ice Formation and Oxidative Damage" International Journal of Molecular Sciences 24, no. 7: 6696. https://doi.org/10.3390/ijms24076696

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop